These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3733283)

  • 1. The repeated one-point method for predicting dose sizes with irregular dosing intervals.
    Thompson GA; Ritschel WA
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):337-43. PubMed ID: 3733283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic comparison of the one-point method with other methods in predicting steady state drug concentrations in multiple dosing.
    Ritschel WA; Erni W
    Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):279-87. PubMed ID: 881281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Developing a dose-administration schedule for drug therapy in childhood].
    Richter O; Reinhardt D; Stutzinger W
    Monatsschr Kinderheilkd; 1983 Feb; 131(2):63-5. PubMed ID: 6843558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug accumulation and dose finding (authors' transl)].
    Kurz H
    Arzneimittelforschung; 1977 Feb; 27(2A):250-3. PubMed ID: 577170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose size and dosing interval determination.
    Ritschel WA
    Arzneimittelforschung; 1975 Sep; 25(9):1442-7. PubMed ID: 1242670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.
    Garrelts JC
    Pharmacotherapy; 1996; 16(2):286-94. PubMed ID: 8820474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug dosing adjustments in patients with chronic kidney disease.
    Munar MY; Singh H
    Am Fam Physician; 2007 May; 75(10):1487-96. PubMed ID: 17555141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of patient compliance on drug concentration profile in multiple doses.
    Wang W; Husan F; Chow SC
    Stat Med; 1996 Mar; 15(6):659-69. PubMed ID: 8731007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients.
    Mann HJ; Wittbrodt ET; Baghaie AA; Cerra FB
    Pharmacotherapy; 1998; 18(2):371-8. PubMed ID: 9545157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles of antibacterial dosing in continuous renal replacement therapy.
    Choi G; Gomersall CD; Tian Q; Joynt GM; Freebairn R; Lipman J
    Crit Care Med; 2009 Jul; 37(7):2268-82. PubMed ID: 19487930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Individualization of drug dosage by therapeutic monitoring in plasma and the application of pharmacokinetic principles].
    Klotz U
    J Clin Chem Clin Biochem; 1983 Nov; 21(11):649-58. PubMed ID: 6655441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choosing optimal sampling times for therapeutic drug monitoring.
    Schumacher GE
    Clin Pharm; 1985; 4(1):84-92. PubMed ID: 3971691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of simulation to develop multiple-dose regimens for drugs exhibiting nonlinear elimination kinetics.
    Hepler CD; Prince RA
    Am J Hosp Pharm; 1980 Dec; 37(12):1631-5. PubMed ID: 7446538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using pharmacokinetics in drug therapy. VI: Comparing methods for dealing with nonlinear drugs like phenytoin.
    Schumacher GE
    Am J Hosp Pharm; 1980 Jan; 37(1):128-32. PubMed ID: 7361770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calculation of drug dosage regimens in patients with renal disease: a new nomographic method.
    Spring P
    Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):76-80. PubMed ID: 1150365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriate dosing regimen of allopurinol in Japanese patients.
    Takada M; Okada H; Kotake T; Kawato N; Saito M; Nakai M; Gunji T; Shibakawa M
    J Clin Pharm Ther; 2005 Aug; 30(4):407-12. PubMed ID: 15985055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design.
    DeVane CL; Gill HS
    J Clin Psychiatry; 1997; 58 Suppl 5():7-14. PubMed ID: 9184622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The one-point method in predicting dosage regimen in case of hepatic and/or renal failure in presence or absence of change in volume of distribution.
    Ritschel WA; Thompson GA
    J Clin Pharmacol; 1979 Jul; 19(7):350-6. PubMed ID: 479379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.